photo of Matthew Baggott, PhD

Matthew Baggott, PhD

Co-Founder & Ceo

Matthew is a neuroscientist with a three-decade-plus career that includes data science, preclinical pharmacology, genomics, clinical trials, and drug development. Matthew started his career in the first lab to study the long-term effects of MDMA on the brain. He next moved to a psychopharmacology lab at UCSF that focused on clinical trials for substance use disorder pharmacotherapies. Matthew later consulted with MAPS, drafting regulatory documents to help them gain FDA permission to start Phase 2 trials with MDMA. Other career highlights include work to develop the formulation for Suboxone, conducting the first federally funded clinical studies of MDMA, and conducting the first modern clinical study of the related compound MDA.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

Events featuring Matthew Baggott, PhD
Events featuring Matthew Baggott, PhD